In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related ...

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in ...

Discover the best marijuana ETFs to invest in, offering diversified exposure to the cannabis industry with growth potential and reduced risk.

In a landmark policy shift, the Trump administration reclassified medical marijuana from a Schedule I to a Schedule III controlled substance in late April 2026, marking the most significant federal ...

Trump ordered marijuana reclassification from Schedule I to III. This eliminates Section 280E tax penalties that force cannabis firms to pay taxes on gross income. CNBS holds $79M across just five ...

President Trump will reschedule marijuana as a Schedule III drug under the Controlled Substances Act, a major move that would allow for greater research of the plant, make it easier for pharma ...

The AdvisorShares Pure U.S. Cannabis ETF (NYSE: MSOS), which invests in U.S. marijuana and hemp stocks, is seeing a surge in Momentum, according to Benzinga’s Edge Stock Rankings, as Washington starts ...

Quick Read AdvisorShares Pure US Cannabis ETF (MSOS) gained 31% in one month and 69% over the past year by holding US multi-state operators through total return swaps, directly benefiting from Section ...

For investors seeking momentum, Roundhill Cannabis ETF WEED is probably on the radar now. The fund just hit a 52-week high and is up 226.5% from its 52-week low price of $8.79 per share. But are there ...

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. The contraction of the product lineup has left a smaller ...